tiprankstipranks
Emergent Biosolutions (EBS)
NYSE:EBS
US Market

Emergent Biosolutions (EBS) Income Statement

Compare
1,266 Followers

Emergent Biosolutions Income Statement

Last quarter (Q3 2024), Emergent Biosolutions's total revenue was $293.80M, an increase of 8.61% from the same quarter last year. In Q3, Emergent Biosolutions's net income was $114.80M. See Emergent Biosolutions’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 1.05B$ 1.12B$ 1.79B$ 1.56B$ 1.11B
Gross Profit
$ 343.90M$ 427.20M$ 1.04B$ 1.03B$ 672.50M
Operating Expenses
$ 1.04B$ 593.20M$ 640.90M$ 597.60M$ 558.40M
Depreciation and Amortization
$ 125.10M$ 148.90M$ 126.30M$ 114.40M$ 110.90M
EBITDA
$ -505.30M$ -32.90M$ 458.20M$ 549.00M$ 227.30M
Operating Income
$ -726.40M$ -166.00M$ 352.60M$ 433.80M$ 114.10M
Other Income/Expenses
$ -4.80M$ -53.00M$ -38.20M$ -26.60M$ -36.70M
Pretax Income
$ -731.20M$ -221.70M$ 314.40M$ 407.20M$ 77.40M
Net Income
$ -760.50M$ -223.80M$ 219.50M$ 305.80M$ 54.50M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -14.85$ -4.47$ 4.10$ 5.79$ 1.06
Diluted EPS
$ -14.85$ -4.47$ 4.06$ 5.67$ 1.04
Weighted Average Shares Outstanding
51.20M 50.10M 53.50M 52.70M 51.50M
Weighted Average Shares Outstanding (Diluted)
51.20M 50.10M 54.10M 53.80M 52.40M
Currency in USD

Emergent Biosolutions Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis